| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2575 | Hmr-1566 | Potent and selective I ks channel blocker |
|
| DCC2576 | Hmref-s-neu5ac | Novel sialidase-activatable fluorescence probe with improved stability for the sensitive detection of sialidase |
|
| DCC2577 | Hmref-ßglcnac | Novel Hexosaminidase-Targeting Fluorescence Probe for Visualizing Human Colorectal Cancer. |
|
| DCC2578 | Hms-i1 | Novel chemical probe for heterochromatin formation and function, disrupting of heterochromatin-mediated transcriptional gene silencing |
|
| DCC2579 | Hms-i2 | Novel chemical probe for heterochromatin formation and function, disrupting of heterochromatin-mediated transcriptional gene silencing |
|
| DCC2580 | Hmsir-tubulin | Novel Blinking Fluorescent Probe for Tubulin Nanoscopy in Living and Fixed Cells |
|
| DCC2581 | Hn-cbl | Novel selective inhibitor of the lymphocytic leukemia (LL) cell survival , Selectively Enhancing the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo |
|
| DCC2582 | Hnpc-a3066 | Novel strobilurin acaricide, exhibiting larvicidal and ovicidal activities against various acarids |
|
| DCC2583 | Hocpca | Highly potent and selective ligand for the GHB binding sites, binding with 27 times better affinity than GHB itself and acrossing the blood brain barrier in vitro and in vivo |
|
| DCC2584 | Hoechst-3325 | Fluorescent indicator of apoptosis, binding the minor groove of DNA at A and T rich regions |
|
| DCC2585 | Hoi-07 | Novel specific Aurora B inhibitor |
|
| DCC2586 | Holomycin | Antibiotic |
|
| DCC2587 | Holothurin A | Natural inhibitor of dietary fat absorption and showing strong anti-obesity activity |
|
| DCC2588 | Homochlorcyclizine Dihydrochloride | Histamine H1 receptor antagonist |
|
| DCC2589 | Homovanillyl Sinapate | Novel c-Met inhibitor, markedly reducing tumor growth, showing excellent pharmacodynamics, and suppressing cell proliferation and microvessel density in an orthotopic model of triple negative breast cancer |
|
| DCC2590 | Hpta-1 | Novel highly selective switch-on fluorescence sensor, targeting telomeric dimeric G-quadruplex, discriminating the telomeric dimeric G-quadruplex TTA45 against other types of DNA structures accompanied by a drastic enhancement of the emission intensity wi |
|
| DCC2591 | Hpxr-agonist-28 | Novel silanol-based human pregnane X receptor (PXR) agonist |
|
| DCC2592 | Hr1405-01 | Loxoprofen active metabolite, acting as a safe intravenous NSAID with superior anti-inflammatory and analgesic activities |
|
| DCC2593 | Hras-1y I-motif Probe-1 | Novel Probe of the hras-1Y i-motif , selectively and directly interacting with the hras-1Y i-motif. |
|
| DCC2594 | Hrv-14 Inhibitor 3v | Inhibitor of human rhinoviruses serotype 14 (HRV-14) |
|
| DCC2595 | Hs-438 | Novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia |
|
| DCC2596 | Hs-731 | μ-Opioid Receptor Agonist |
|
| DCC2597 | Hsa-5b | Novel anticancer Gold(III) agent with remarkable cytotoxicity to gastric cancer cells |
|
| DCC2598 | Hsd1237 | Novel potent inhibitor of the recombinant FLT3 kinase and its mutant forms, blocking the proliferation of AML cell lines, harboring oncogenic FLT3-ITD mutations with remarkable IC50 values, which were comparable to the approved FLT3 inhibitor quizartinib, |
|
| DCC2599 | Hsgn-94 | Novel inhibitor of lipoteichoic acid (LTA) biosynthesis, potently inhibiting S. aureus and E. faecalis growth and biofilm formation |
|
| DCC2600 | Hsk21542 | Novel Peripherally-Restricted Kappa Opioid Receptor (KOR) Agonist with Antinociceptive and Antipruritic Effects |
|
| DCC2601 | Hsp27-in-i | Novel inhibitor of heat shock 27 kDa protein (HSP27), significantly inducing AR degradation in GBM cells via the proteasomal pathway, selectively inhibiting AR-overexpressed GBM cell growth with IC 50 values around 5 nM |
|
| DCC2602 | Hsp90-aha1 Inhibitor A16 | Novel Hsp90-Aha1 chaperone complex formation inhibitor, enhancing F508del-CFTR channel activity |
|
| DCC2603 | Hsp90-in-30f | Novel potent inhibitor of heat shock protein 90 (Hsp90), effectively reducing the expression levels of Hsp90 client proteins including Her2, EGFR, Met, Akt, and c-Raf |
|
| DCC2604 | Hsp90-in-89 | Novel heat shock protein 90 (Hsp90) inhibitor |
|
